Education
About Us
Working with TipRanks
Follow Us
Daré Bioscience Inc (DARE)
NASDAQ:DARE
Earnings Data
Report Date
Mar 26, 2026TBA (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
-0.43Last Year’s EPS
-0.61Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call highlighted significant advancements in Daré Bioscience's commercial and clinical pipeline, supported by strong financial management and strategic partnerships. However, increased expenses and limitations in capital generation were noted concerns. Overall, the positive developments in the product pipeline and financial position outweigh the challenges.Company Guidance
Commercial Launch of DARE to PLAY Sildenafil Cream
Daré Bioscience is on track to launch DARE to PLAY Sildenafil Cream through a 503B outsourcing facility by the end of the year, marking a major milestone for women's sexual health.
Strong Financial Position
The company ended the quarter with approximately $23 million in cash and cash equivalents and received $18.7 million from sales of common stock and $7.3 million in grant payments.
Grant-Funded Programs Advancing
Key programs like Ovaprene and DARE-HPV are advancing with support from grants, demonstrating strategic collaborations and disciplined capital allocation.
Upcoming Product Launches
The company plans to introduce DARE to RESTORE vaginal probiotic products in Q1 2026 and DARE to RECLAIM hormone therapy in early 2027.
DARE Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
DARE Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 13, 2025 | $1.89 | $1.86 | -1.59% |
Aug 14, 2025 | $2.07 | $2.20 | +6.28% |
May 13, 2025 | $2.89 | $2.89 | 0.00% |
Mar 31, 2025 | $2.89 | $2.90 | +0.35% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Daré Bioscience Inc (DARE) report earnings?
Daré Bioscience Inc (DARE) is schdueled to report earning on Mar 26, 2026, TBA (Confirmed).
What is Daré Bioscience Inc (DARE) earnings time?
Daré Bioscience Inc (DARE) earnings time is at Mar 26, 2026, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is DARE EPS forecast?
DARE EPS forecast for the fiscal quarter 2025 (Q4) is -0.43.